Dare Bioscience, Inc. Preferred Stock, Liquidation Preference, Value
Dare Bioscience, Inc. (DARE) had Preferred Stock, Liquidation Preference, Value of $400.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockLiquidationPreferenceValue · last filed 2026-08-13
- 2026-06-30: Preferred Stock, Liquidation Preference, Value $400.00K.
- 2026-03-31: Preferred Stock, Liquidation Preference, Value $328.20K.
- 2025-12-31: Preferred Stock, Liquidation Preference, Value $0.00.
| Period end | Preferred Stock, Liquidation Preference, Value |
|---|---|
| 2026-06-30 | $400.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $328.20K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |